martes, 30 de julio de 2013

FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems

FDA (U.S. Food and Drug Administration)
What's New on the FDA Drugs Site
July 26, 2013

No hay comentarios:

Publicar un comentario